Kutatási jelek – Signal Engine

• Multiple Myeloma - StatPearls - NCBI Bookshelf — Multiple myeloma
• HER2-Targeted Therapies in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis — Colorectal cancer
• Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia — Leukemia
• Precision Diagnostics in Prostate Cancer Treatment (PREDICT): A Phase II Multiarm Biomarker-Based Study (Alliance A032102) — Prostate cancer
• EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma — Glioblastoma
• GLP-1 Agonists Are Associated With a Significant Reduction in Breast Cancer Incidence in Women. — Breast cancer
• Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer — Breast cancer
• Hallmarks of liver cancer: Therapeutic implications — Hepatocellular carcinoma
• Genomic landscape and therapeutic implications of Anaplastic Lymphoma Kinase fusion-positive colorectal cancer — Colorectal cancer
• Ensartinib in Resected ALK‑Positive Non‑Small‑Cell Lung Cancer — NSCLC
• First-line osimertinib in advanced EGFR-mutated NSCLC: real-world outcomes, clinicogenomic correlates, and oligoprogression management in a multicenter Spanish cohort — NSCLC
• Emerging and Established Targets in Colorectal Cancer: Translating Biology Into Therapeutics — Colorectal cancer
• Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma — Lymphoma
• Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer — Gastric cancer
• Uttroside B, a US FDA-designated ‘Orphan Drug’, mitigates the development of hepatocellular carcinoma and its pulmonary metastasis via EGFR/ERK-mediated inhibition of SREBP-1 and STAT-3 — Hepatocellular carcinoma
• Quercetin suppresses the progression of HBV-associated hepatocellular carcinoma by modulating the EGFR signaling pathway — Hepatocellular carcinoma
• Can ovarian cancer screening work? A secondary analysis of the UK collaborative trial of ovarian cancer screening — Ovarian cancer
• Contemporary management of locally advanced prostate cancer: a narrative review and expert perspective — Prostate cancer
• Prognostic impact of TP53 mutations in diffuse large B-cell lymphoma — Hepatocellular carcinoma
• Update 2026: Management of Small Cell Lung Cancer — SCLC